Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 22, 2007. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details specific share transactions executed on January 19, 2007, involving the GlaxoSmithKline (US) Trust ("the GSK US Trust"):
- Sale: The Trust sold 1,626 Ordinary Share ADRs on behalf of participants in the GlaxoSmithKline Share Value Plan at a price of $55.77 per ADR.
- Transfer: The Trust transferred 2,765 Ordinary Share ADRs to participants in the GlaxoSmithKline Share Value Plan.
These transactions were advised to the Company on January 19, 2007.
Outlook, Risks, and Management Commentary
The filing notes that the GSK US Trust is a grantor trust where all employees or former employees of SmithKline Beecham Corporation and its subsidiaries are potential beneficiaries. Consequently, two directors, Dr. J-P Garnier and Dr. M M Slaoui, hold an interest in the shares held in the GSK US Trust in the same manner as other employees or former employees of SmithKline Beecham Corporation and its subsidiaries. No other risks, contingencies, or forward-looking guidance are provided in this text.
Investor Verification Checklist
- Verify the total number of ADRs sold (1,626) and transferred (2,765) on January 19, 2007.
- Confirm the transaction price of $55.77 per ADR for the sale executed by the GSK US Trust.
- Review the relationship between the GSK US Trust and the directors Dr. J-P Garnier and Dr. M M Slaoui regarding their beneficial interest.
- Note that this filing does not contain financial results; refer to Form 20-F for comprehensive financial data.